Science ❯Biotechnology ❯Pharmaceutical Research ❯Cancer Drug Development

Radioconjugate Technology

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline